MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Postural Instability Assessed by Static and Dynamic Posturography in the Early Stage of Parkinson’s Disease

    A. Hajas, TW. Stone, E. Dinya, J. Málly (Sopron, Hungary)

    Objective: The early stage of Parkinson’s disease (PD) (Hoehn-Yahr (HY) I-II stages) is characterized by a negative pull test, which clinically excludes postural instability. Previous…
  • 2019 International Congress

    Availability of Parkinson’s disease medicines in Ghana: a national survey

    M. Cham, I. Sefah, K. Oppon, R. Odikro, C. Amenorvi, A. Malik, J. Duah, G. Pezzoli, F. Baiden, R. Cilia (Sogakope, Ghana)

    Objective: To determine the affordability, availability, geographic distribution and financing options of Parkinson’s disease (PD) medication in Ghana. Background: In sub-Saharan Africa, patients with PD…
  • 2019 International Congress

    Amplification of α-synuclein aggregates in cerebrospinal fluid by rapid ultrasonication-based assay

    K. Kakuda, K. Ikenaka, K. Araki, Y. Kajiyama, M. So, T. Ohmichi, Y. Nagai, T. Tokuda, Y. Goto, H. Mochizuki (Suita, Japan)

    Objective: To apply an ultrasonication-based misfolded  protein amplification to the evaluation of α-synuclein aggregates in CSF, and to investigate their clinical significances in Parkinson’s disease…
  • 2019 International Congress

    Evaluating the real-world effectiveness of carbidopa/levodopa enteral suspension (CLES) on patients with advanced Parkinson’s disease in USA: Interim-evidence from the PROviDE study

    R. Pahwa, S. Isaacson, P. Kandukuri, Y. Jalundhwala, P. Kukreja, Y. Bao, N. Gupta, I. Pan, J. Aldred (Kansas City, KS, USA)

    Objective: To evaluate the real-world effectiveness of carbidopa/levodopa enteral suspension (CLES) in patients with advanced Parkinson’s disease (PD) in real world at home setting in…
  • 2019 International Congress

    Ataxin-2 gene in the Cuban population: Mutagenesis and epigenetic DNA methylation disease influencing phenotype

    J. Laffita-Mesa, L. Velazquez Perez (Stockholm, Sweden)

    Objective: To characterize genetics and epigenetics factors contributing to the origin and accounting to the Cuban SCA2 phenotype variability. Background: CAG repeat expansions in ATXN2…
  • 2019 International Congress

    Apathy : Clinical Correlates in Parkinson’s disease Psychosis

    YM. Wan, D. van Wamelen, V. Leta, D. Trivedi, A. Podlewska, TS. Lee, EK. Tan, D. Aarsland, K. Chaudhuri (London, United Kingdom)

    Objective: To determine the frequency and clinical correlates of apathy in Parkinson’s disease (PD) psychosis. Background: The underlying pathology of apathy in PD psychosis, itself…
  • 2019 International Congress

    GBA p.Glu326Lys substitution increases the risk to develop Parkinson’s disease; is it enough to affect disease phenotype?

    O. Goldstein, M. Gana- Weisz, D. Cohen-Avinoam, A. Bar-Shira, A. Thaler, T. Shiner, A. Mirelman, N. Giladi, A. Orr-Urtreger (Tel Aviv, Israel)

    Objective: To evaluate the frequency of GBA p.Glu326Lys (E326K) carriers in a large cohort of Parkinson's disease patients of Ashkenazi Jewish origin (AJPD) and to…
  • 2019 International Congress

    GBA and ATP13A mutation and PD: clinical phenotype, eye movements and pathogenic implications

    GM. Riboldi, J. Martone, J. Rucker, JR. Rizzo, T. Hudson, W. Dauer, S. Frucht (New York, NY, USA)

    Objective: To characterize a patient with GBAand ATP13A2gene mutations. Background: Mutations of GBA(Glucocerebrosidase) and ATP13A2(P5-ATPase) genes are risk factors for Parkinson’s disease (PD). Homozygous mutations…
  • 2019 International Congress

    Creutzfeldt-Jakob disease with a M232R substitution (CJD232) masquerading as parkinson look-alike syndrome

    KO. Jung, H. Kim, JH. Park (Bucheon-Si, Republic of Korea)

    Objective: To describe a case of Creutzfeldt-Jakob disease with a M232R substitution (CJD 232) presented with parkinson look-alike syndrome and showed remarkably long survival time.…
  • 2019 International Congress

    Sleep disordered breathing and REM sleep behavior disorder in military Veterans with Parkinson’s disease

    A. Sarwar, S. Moore (Houston, TX, USA)

    Objective: To study the association of sleep disordered breathing with REM sleep behavior disorder in US military Veterans with Parkinson’s disease. Background: Both REM sleep…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley